Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Japanese females generally have longer, denser, and curlier eyelashes than males.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Baricitinib is effective and safe for treating severe alopecia areata.

Bimatoprost ophthalmic solution 0.03% safely and effectively increases eyelash growth when applied to the upper eyelid.

Hand-foot-mouth disease may cause nail loss in children.

Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Latanoprost can make eyelashes longer, thicker, and darker.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.